Accreditation

Joint Commission rescinds interim action to MM.4.10

Briefings on Accreditation and Quality, June 4, 2007

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on Accreditation and Quality.

Hospitals still trying to comply with prospective pharmacist reviews

After reading this article, you will be able to:

1. Explain what the interim action to MM.4.10 means

2. Describe ways to overturn an RFI for MM.4.10, EP 1,in an emergency department (ED)

In a memo to hospitals on April 9, The Joint Commission indefinitely rescinded the interim action for MM.4.10, EP 1, for EDs. The decision effectively ended the requirement for a retrospective pharmacy review of all drugs administered in the ED that do not receive a prospective review.

This is an excerpt from a member only article. To read the article in its entirety, please login or subscribe to Briefings on Accreditation and Quality.

Most Popular